Biora Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview

Biora Therapeutics

12/11/2022 24:26

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to show a
fall in quarterly revenue when it reports  results on November
14. 
    * The San Diego California-based  company is expected to
report  a
72.5% decrease in revenue to $50 thousand from $182 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biora Therapeutics
Inc is
for a loss of 7 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $5​, above​ its last closing price of $0.28.
​​​

This summary was machine generated November 12 at 00:26 GMT. 
All figures in US dollars  unless otherwise stated